Home › Funds › Citigroup Inc › ASND
Citigroup Inc position in ASND
ASCENDIS PHARMA A/S · Health Care
Latest position (Q2 2026)28.69K sh
Reported value held$7.65M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.55K | $566.00K | New |
| Q4 2021 | 2.44K | $328.00K | Reduce |
| Q1 2022 | 1.90K | $223.00K | Reduce |
| Q2 2022 | 1.60K | $149.00K | Reduce |
| Q3 2022 | 1.28K | $132.00K | Reduce |
| Q4 2022 | 67.17K | $8.20M | Add |
| Q1 2023 | 83.69K | $8.97M | Add |
| Q2 2023 | 880.00K | $798.60K | Add |
| Q3 2023 | 1.08M | $985.50K | Add |
| Q4 2023 | 1.08M | $1.10M | Hold |
| Q1 2024 | 69.58K | $10.52M | Reduce |
| Q2 2024 | 1.88M | $2.09M | Add |
| Q3 2024 | 1.19M | $1.38M | Reduce |
| Q4 2024 | 2.34M | $2.57M | Add |
| Q1 2025 | 1.85M | $2.19M | Reduce |
| Q2 2025 | 1.95M | $2.43M | Add |
| Q3 2025 | 1.66M | $2.26M | Reduce |
| Q4 2025 | 2.22M | $3.14M | Add |
| Q1 2026 | 53.70K | $12.28M | Reduce |
| Q2 2026 | 28.69K | $7.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ASND
- Fidelity Management & Research (FMR) 3.55M sh · $945.68M · Q2 2026
- BlackRock Inc 2.21M sh · $589.94M · Q2 2026
- MFS Investment Management 1.88M sh · $500.14M · Q2 2026
- Franklin Resources 1.86M sh · $496.77M · Q2 2026
- Wellington Management Group 1.55M sh · $413.05M · Q2 2026
- Capital World Investors 906.08K sh · $241.67M · Q2 2026
- Principal Global Investors 873.50K sh · $232.98M · Q2 2026
- Goldman Sachs Group 559.53K sh · $149.24M · Q2 2026
- Morgan Stanley 544.39K sh · $145.20M · Q2 2026
- Invesco Ltd 414.20K sh · $110.47M · Q2 2026
- Geode Capital Management 403.15K sh · $107.53M · Q2 2026
- UBS Group AG 401.88K sh · $107.19M · Q2 2026